Legacy Reserves LGCY Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by Legacy Reserves in its filing.
Tagged under the XBRL concept LGCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice.
The official record: Legacy Reserves’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Legacy Reserves's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Legacy Reserves's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price?
- Legacy Reserves (LGCY) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price of $6.04 in Q1 2026.
- How has Legacy Reserves's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price changed year-over-year?
- Legacy Reserves's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price increased by 56.9% year-over-year, from $3.85 to $6.04.
- What does share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average exercise price mean?
- This metric represents the weighted average grant-date fair value or exercise price of non-vested equity instruments, excluding stock options, issued under share-based compensation plans. It provides insight into the potential future dilution and the cost basis of equity-based incentives granted to employees and directors. Monitoring this value helps investors assess the company's long-term commitment to equity-based compensation and its impact on shareholder equity.